FDA’s new rare disease framework aims to leverage patient voices for better innovation
· biospace.com · popularity 14/100 · 0 similar stories today · Chronic Conditions (Health & Life Sciences)
Read the original at biospace.com →
Summary
The voices of patients with a rare disease are sometimes heard by the FDA—at listening sessions and during advisory committee meetings—but for …
Found in: Innovation. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 26.